Industry reports
Editor highlights

Bicalutamide Key patent SPC and data exclusivity expiry 7 country coverage

We are sorry but this premium report expired!

This market research, not available anymore on the publisher's website, was withdrawn from our database.

To get an alternative report, you can either :

  • Have a look at the list of documents hereafter
  • Launch a new search below

Search ReportLinker

The Largest Collection of Market Research Reports

» 1.2 Million Industry Reports
» 450,000 Company Profiles
» 850,000 Market Briefings
» 40,000 Country Guides

From +200,000 authoritative sources

DOWNLOAD THESE REPORTS NOW!

Mylan Laboratories Limited - Strategic SWOT Analysis Review

Mylan Laboratories Limited - Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • by Global Data
  • February 2014
  • 15 pages

Summary Mylan Laboratories Limited (Mylan Laboratories) is a pharmaceutical company. The company's product segments include manufacturing and supply of active pharmaceutical ingredients (APIs). The company offers its products in various therapeutic categories, including central nervous system (CNS) agents, ...

Industries: Drug and Medication | Countries: United States, India, World, Australia, South Africa, China

Henderson Morley Plc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Henderson Morley Plc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Industry report
  • by Global Data
  • February 2014
  • 19 pages

Summary Henderson Morley Plc (Henderson Morley) is a biotechnology company engaged in the development of anti-viral drugs and vaccines and biological products for a wide range of diseases in humans and animals. It develops in-house discoveries up to a stage which could be licensed to pharmaceutical o ...

Industries: Drug and Medication | Countries: Australia

Australia Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

Australia Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

  • $ 1 300
  • Industry report
  • by Business Monitor International
  • February 2014
  • 128 pages

BMI View: Australia’s pharmaceutical segment will get increasingly more regulated as the government seeks to make improvements for creating a more transparent environment, benefiting all stakeholders: government, manufacturers and the public. Given the country’s precarious economic situation, we ...

Industries: Drug and Medication | Countries: Australia

Australia Pharmaceuticals and Healthcare Report Q1 2014

Australia Pharmaceuticals and Healthcare Report Q1 2014

  • $ 1 300
  • Industry report
  • by Business Monitor International
  • February 2014
  • 126 pages

Includes 3 FREE quarterly updates BMI View: We maintain our broad view toward Australia's pharmaceutical and healthcare sectors, as new Prime Minister Tony Abbott stated that 'there will be no cuts to health'. While the country's ageing population will continue to spur demand for medical services, we ...

Industries: Drug and Medication | Countries: Australia

Edmond Pharma Srl - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Edmond Pharma Srl - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • by Global Data
  • January 2014
  • 20 pages

Summary Edmond Pharma Srl (Edmond Pharma) is a pharmaceutical company. The company produces active ingredients, finished products, and pharmaceutical specialties for generic market. It operates through two divisions such as chemical plant and pharmaceutical plant. The company's active ingredients include ...

Industries: Drug and Medication | Countries: Australia

Avexa Limited (Symbol:AVX) SWOT Analysis, Strategy, Revenues and Profits

Avexa Limited (Symbol:AVX) SWOT Analysis, Strategy, Revenues and Profits

  • $ 125
  • Company report
  • by Global Data
  • January 2014
  • 34 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. Avexa Limited SWOT Analysis report provides you a strategic analysis ...

Industries: Drug and Medication | Countries: Australia

Aspen Pharmacare Holdings Ltd (Symbol:APN) SWOT Analysis, Strategy, Revenues and Profits

Aspen Pharmacare Holdings Ltd (Symbol:APN) SWOT Analysis, Strategy, Revenues and Profits

  • $ 125
  • Company report
  • by Global Data
  • January 2014
  • 38 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. Aspen Pharmacare Holdings Ltd SWOT Analysis report provides you a ...

Industries: Drug and Medication | Countries: Australia, South Africa, World, Brazil, Mexico, Germany, Tanzania, Kenya, Africa, Venezuela, Mauritius

IDT Australia Limited (Symbol:IDT) SWOT Analysis, Strategy, Revenues and Profits

IDT Australia Limited (Symbol:IDT) SWOT Analysis, Strategy, Revenues and Profits

  • $ 125
  • Company report
  • by Global Data
  • January 2014
  • 30 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. IDT Australia Limited SWOT Analysis report provides you a strategic ...

Industries: Drug and Medication | Countries: Australia

Haemophilus Influenzae Type b Infections - Pipeline Review, H2 2013

Haemophilus Influenzae Type b Infections - Pipeline Review, H2 2013

  • $ 2 000
  • Company report
  • by Global Markets Direct
  • November 2013
  • 55 pages

Haemophilus Influenzae Type b Infections - Pipeline Review, H2 2013 Summary Global Markets Direct's, 'Haemophilus Influenzae Type b Infections - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development fo ...

Industries: Drug and Medication | Countries: India, World, Australia

Global Testosterone Replacement Therapy (TRT) Industry

Global Testosterone Replacement Therapy (TRT) Industry

  • $ 4 950
  • Industry report
  • by Global Industry Analysts
  • October 2013
  • 152 pages

This report analyzes the worldwide markets for Testosterone Replacement Therapy (TRT) in US$ Million. The global and the US markets are further analyzed by the following Product Segments: Topicals, Patches, and Others. The report provides separate comprehensive analytics for the US, Canada, Europe, Asia-Pacific, ...

Industries: Drug and Medication | Countries: World, United States, Canada, Europe, Germany, Italy, France, United Kingdom, North America, Australia

24/7 Customer Service

You can call our customer service 24 hours a day / 7 days a week

  • +1 917 267 7886

ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.